 - Compare the efficacy of docetaxel followed by doxorubicin hydrocloride and cyclophosphamide AC vs docetaxel and capecitabine followed by AC vs docetaxel and gemcitabine hydrochloride followed by AC, with or without bevacizumab, in terms of an increase in the rate of pathologic complete response pCR in the breast, in women with palpable or operable breast cancer. 